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Periprosthetic joint infection (PJI) in shoulder arthroplasty 
remains a diagnostic and management conundrum. The 
reported infection rate after primary shoulder arthroplasty 
is just under 1%1) and it is approximately 5% after primary 
reverse shoulder arthroplasty.2) Treatment options include 
antibiotic treatment, irrigation and debridement, single-
stage revision, two-stage revision, resection arthroplasty, 
and arthrodesis.3-9) While there is no definitive standard 
of care for the treatment of infected shoulder arthroplasty, 
two-stage revision is often utilized in a similar fashion to 
the common practice in hip and knee PJI.10-14) Placement 
of an antibiotic spacer may be a bridge to a definitive ar-
throplasty with a two-stage revision or a definitive man-
agement option for PJI. Stine et al.15) showed that the use 
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Background: Antibiotic spacers in shoulder periprosthetic joint infection deliver antibiotics locally and provide temporary stability. 
The purpose of this study was to evaluate differences between stemmed and stemless spacers.
Methods: All spacers placed from 2011 to 2013 were identified. Stemless spacers were made by creating a spherical ball of ce-
ment placed in the joint space. Stemmed spacers had some portion in the humeral canal. Operative time, complications, reimplan-
tation, reinfection, and range of motion were analyzed. 
Results: There were 37 spacers placed: 22 were stemless and 15 were stemmed. The stemless spacer population was older (70.9 ± 
7.8 years vs. 62.8 ± 8.4 years, p = 0.006). The groups had a similar percentage of each gender (stemless group, 45% male vs. stemmed 
group, 40% male; p = 0.742), body mass index (stemless group, 29.1 ± 6.4 kg/m2 vs. stemmed group, 31.5 ± 8.3 kg/m2; p = 0.354) and 
Charlson Comorbidity Index (stemless group, 4.2 ± 1.2 vs. stemmed group, 4.2 ± 1.7; p = 0.958). Operative time was similar (stemless 
group, 127.5 ± 37.1 minutes vs. stemmed group, 130.5 ± 39.4 minutes). Two stemless group patients had self-resolving radial nerve 
palsies. Within the stemless group, 15 of 22 (68.2%) underwent reimplantation with 14 of 15 having forward elevation of 109º ± 23º. 
Within the stemmed group, 12 of 15 (80.0%, p = 0.427) underwent reimplantation with 8 of 12 having forward elevation of 94º ± 43º 
(range, 30º to 150º; p = 0.300). Two stemmed group patients had axillary nerve palsies, one of which self-resolved but the other did not. 
One patient sustained dislocation of reverse shoulder arthroplasty after reimplantation. One stemless group patient required an open 
reduction and glenosphere exchange of dislocated reverse shoulder arthroplasty at 6 weeks after reimplantation.
Conclusions: Stemmed and stemless spacers had similar clinical outcomes. When analyzing all antibiotic spacers, over 70% 
were converted to revision arthroplasties. The results of this study do not suggest superiority of either stemmed or stemless antibi-
otic spacers.
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of an articulating spacer was a suitable definitive treatment 
option in some patients; however, others experienced per-
sistent pain and limited function that led to reimplanta-
tion. 
The topic of antibiotic spacer types has been well-
studied in two-stage revision for hip and knee PJI. Recent 
analyses have suggested that dynamic spacers have im-
proved functional outcomes and better soft tissue preser-
vation when compared to static spacers.16-18) Furthermore, 
the use of dynamic spacers in two stage-revision knee 
arthroplasty allows for increased range of motion through-
out the treatment with the spacer leading to reduced bone 
loss and less muscle atrophy without any evidence of 
significant wear damage.19) In shoulder PJI, there are two 
main categories of antibiotic spacers utilized in two-stage 
revisions: stemmed and stemless. The clinical differences 
between these two implant choices have not yet been stud-
ied. For the purpose of this study, any antibiotic spacer 
that had any cement that entered into the humeral canal 
was considered a stemmed implant while any implant that 
was formed by simply creating a sphere of cement that was 
placed into the joint cavity after debridement was consid-
ered stemless. The purpose of this study was to evaluate all 
patients who underwent antibiotic spacer placement and 
evaluate differences in outcomes between the stemmed 
and stemless implants. 
METHODS
The study was approved by the Institutional Review Board 
of Thomas Jefferson University Hospital (IRB No. 45 CFR 
46.110; #16D.594) and performed in accordance with the 
principles of the Declaration of Helsinki. Informed con-
sent was waived as this was purely retrospective review 
without intervention. After approval from the Institutional 
Review Board, we performed a retrospective analysis of 
our institutional shoulder arthroplasty database between 
January 1, 2011 and December 31, 2013. This database 
identified all primary and revision shoulder arthroplasty 
cases defined by the International Classification of Dis-
eases, ninth revision, clinical modification (ICD-9-CM) 
codes. The codes utilized were 79.31 (open reduction of 
fracture of humerus), 80.01 (arthrotomy for removal of 
a prosthesis without replacement), 81.80 (total shoulder 
arthroplasty), 81.81 (shoulder hemiarthroplasty), 81.82 
(repair of recurrent dislocation of shoulder), 81.83 (other 
repair of shoulder, arthroplasty), 81.88 (reverse total shoul-
der arthroplasty), and 81.97 (revision joint replacement 
upper extremity). Direct chart review was then performed 
to identify the subpopulation of patients that underwent 
placement of an antibiotic spacer. Operative notes and 
postoperative radiographs were utilized to determine if the 
antibiotic spacer was stemmed (Fig. 1) or stemless (Fig. 2). 
Prefabricated implants were not utilized. All spacers were 
created with tobramycin and vancomycin. All stemless 
spacers were made by creating a spherical ball of cement 
that was placed in the joint space. Any antibiotic spacer 
that had any cement that entered into the humeral canal 
was considered a stemmed implant. All stemmed spac-
ers were created by fashioning cement into the shape of a 
stemmed humeral implant, with or without placement of a 
central, pre-bent wire. Complete medical records were re-
viewed to determine the total operative time from skin in-
cision to skin closure in each case as well as complications. 
Fig. 1. Anteroposterior radiograph of a stemmed implant. Fig. 2. Anteroposterior radiograph of a stemless implant.
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Operative cultures were reviewed for identification of in-
fecting organism(s). Postoperative clinic notes at 2, 6, and 
12 weeks as well as the final clinic note in our electronic 
medical records were reviewed to determine whether or 
not patients underwent reimplantation, the timing of re-
implantation, and final range of motion after reimplanta-
tion. At a minimum of 2 years of clinical follow-up, recur-
rence of infection and any future reoperations following 
reimplantation were determined. 
Descriptive statistics were utilized to compare the 
two antibiotic spacer subpopulations. Differences in cat-
egorical variables were evaluated by comparison of z-
scores of proportions while continuous variables were 
evaluated by Student paired t-tests. Preoperative variables 
compared between two spacer subpopulations were age, 
gender, body mass index (BMI), and age-adjusted Charl-
son Comorbidity Index (CCI).20,21) The operative times of 
antibiotic spacer placement were then compared between 
the two groups. The rates of reimplantation (second stage 
of the two-stage revision) were analyzed. Finally, in pa-
tients who underwent reimplantation, range of motion in 
forward elevation was measured at the latest postoperative 
visit (minimum 6 months). This range of motion data was 
directly collected by the surgeon. All statistics were calcu-
lated with Microsoft Excel 2013 (Redmond, WA, USA).
RESULTS
Retrospective review of our institutional shoulder arthro-
plasty database identified 37 patients who underwent 
antibiotic spacer placement over the study period. There 
were 22 stemless implants (59.5%) placed and 15 stemmed 
implants (40.5%). The stemless group had an average age 
of 70.9 ± 7.8 years (range, 54.6 to 84.7 years), was 45.5% 
male, had an average BMI of 29.1 ± 6.4 kg/m2 (range, 19.5 
to 48.0 kg/m2), and had an average age-adjusted CCI of 4.2 
± 1.2 (range, 2 to 6). There were two intraoperative com-
plications in the stemless group; both were nerve injuries 
with electromyography-proven radial nerve palsies that 
self-resolved within 6 months of surgery. The culture data 
from the stemless group revealed that 12 of 22 (54.5%) had 
positive cultures: four isolated Propionibacterium acnes 
(33%), three coagulase-negative Staphylococcus species 
(CNS, 25%), 2 methicillin-sensitive Staphylococcus aureus 
(MSSA, 16.7%), one Enterococcus faecalis (8.3%), one 
Escherichia coli (8.3%), and one with both MSSA and P. 
acnes (8.3%). In comparison, the stemmed group had an 
average age of 62.8 ± 8.4 years (range, 48.0 to 81.9 years; p 
= 0.006), was 40% male (p = 0.742), had an average BMI of 
31.5 ± 8.3 kg/m2 (range, 21.5 to 47.6 kg/m2; p = 0.354), and 
an average age-adjusted CCI of 4.2 ± 1.7 (range, 2 to 8; p 
= 0.958). Operative time for the stemless group was 127.5 
± 37.1 minutes (range, 62 to 200 minutes) compared to 
130.5 ± 39.4 minutes (range, 74 to 188 minutes; p = 0.820) 
Table 1. Comparison of Stemmed and Stemless Groups
Category Stemless (n = 22) Stemmed (n = 15) p-value
Age (yr)*  70.9 ± 7.8 (54.6–84.7) 62.8 ± 8.4 (48.0–81.9) 0.006
Body mass index (kg/m2)*  29.1 ± 6.4 (19.5–48.0) 31.5 ± 8.3 (21.5–47.6) 0.354
Charlson Comorbidity Index* 4.2 ± 1.2 (2–6) 4.2 ± 1.7 (2–8) 0.958
Sex (%)† 0.742
   Male 45.5 40.0
   Female 54.5 60.0
Operative time (min)*
   Index spacer 127.5 ± 37.1 130.5 ± 39.4 0.820
   Reimplantation 143 ± 42  154 ± 70 0.653
Reimplantation (%)† 68.2 80.0 0.427
Forward elevation (º)* 109 ± 23 (70–150) 94 ± 43 (30–150) 0.300
Values are presented as mean ± standard deviation (range) or mean ± standard deviation.
*Comparison of continuous variables calculated by two sample t-test with equal variance. †Comparison of proportional variables calculated by two sample z-test 
for comparing proportions. 
492
Padegimas et al. Stemmed versus Stemless Shoulder Spacers
Clinics in Orthopedic Surgery • Vol. 9, No. 4, 2017 • www.ecios.org
in the stemmed group. There were no intraoperative com-
plications in the stemmed group. The culture data from 
the stemmed group was available for 14 of 15 patients and 
revealed that 7 of 14 (50.0%) had positive cultures: four 
isolated P. acnes (57.1%) and three MSSA (42.8%) (Table 1). 
In the entire antibiotic spacer population, 27 of 37 
patients (73.0%) underwent revision to definitive arthro-
plasty. Within the stemless group, 15 of 22 of patients 
(68.2%) went on to 18 future surgeries (two spacer ex-
changes, 15 reverse shoulder arthroplasties, and one open 
reduction of a dislocated reverse shoulder arthroplasty 
with glenosphere exchange) at an average of 6.8 ± 8.5 
months (range, 0.8 to 34.0 months) after the index spacer 
placement (Table 2). In those stemless patients who were 
converted to a revision arthroplasty, 14 of 15 (93.3%) had 
final range of motion data at an average follow-up of 23.2 
± 11.9 months (range, 6.0 to 44.5 months). These patients 
had an average forward elevation of 109° ± 23° (range, 70° 
to 150°). The operative time for definitive reimplantation 
after stemless spacer placement was 143 ± 42 minutes 
(range, 89 to 236 minutes). There were no intraopera-
tive complications in reimplantation within the stemless 
Table 2. Surgical Variables for All Patients That Underwent Stemless Spacer Placement
Sex Age (yr) Diagnosis at time of spacer placement Months to reimplantation
Surgery at 
reimplantation
Reoperation after 
reimplantation
Female 84.7 Chronically dislocating TSA for OA from OSH NA NA NA
Male 69.1 Infected RTSA for CTA from OSH 36.1 RTSA No
Female 59.6 TSA for PTA with deep infection 18.4 2 Spacer revisions  
and RTSA
No
Female 76.2 Infected RTSA for CTA from OSH NA NA NA
Male 73.4 Infected primary TSA from OSH NA NA NA
Male 73.5 Infected primary TSA from OSH NA NA NA
Female 82.0 Infected HA for CTA from OSH 51.7 RTSA No
Male 54.6 Infected TSA with multiple I&Ds from OSH 40.8 RTSA No
Male 62.6 Chronically dislocating RTSA for CTA from OSH 28.7 RTSA No
Female 68.8 Infected TSA for OA 54.1 RTSA No
Female 66.9 Infected HA for proximal humerus fracture from OSH 63.4 RTSA Open reduction and 
glenosphere  
exchange at 6 weeks
Male 72.7 Primary septic arthritis in setting of CTA 37.4 RTSA No
Female 75.1 Infected TSA with dislocated glenoid from OSH 58.5 RTSA No
Male 61.0 TSA with significant loosening and metallosis 49.2 RTSA No
Female 63.6 Chronically dislocating RTSA for CTA from OSH 32.3 RTSA No
Female 81.9 Nonunion of RTSA periprosthetic fracture 37.0 RTSA No
Female 63.9 Infected RTSA for fracture from OSH NA NA NA
Male 71.5 TSA glenoid and humeral loosening 41.4 RTSA No
Female 71.1 Chronically infected HA from OSH NA NA NA
Female 71.2 Infected TSA for OA 40.8 RTSA No
Male 77.4 Infected RTSA for CTA from OSH 59.9 RTSA No
Male 78.3 Chronically infected TSA from OSH NA NA NA
TSA: total shoulder arthroplasty, OA: osteoarthritis, OSH: outside hospital, NA: not applicable, RTSA: reverse total shoulder arthroplasty, CTA: cuff tear 
arthropathy, PTA: posttraumatic arthritis, HA: hemiarthroplasty, I&D: irrigation and debridement.
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group. Intraoperative cultures were drawn for 14 of 15 
reimplantations in the stemless group with 3 of 15 (20.0%) 
having at least one positive culture: one had negative cul-
tures, but P. acnes were found on gram stain (this patient 
had negative cultures at the index spacer placement), one 
grew P. acnes (this patient had P. acnes at the index spacer 
placement), and one grew CNS (this patient had nega-
tive cultures at the index spacer placement). The first of 
these patients was treated as contaminant, while the other 
two were treated with oral antibiotics for 6 weeks. None 
of these three patients had clinical evidence of infection 
postoperatively. One stemless patient underwent reopera-
tion for a dislocated reverse shoulder arthroplasty at 6 
weeks after reimplantation. This patient required an open 
reduction with glenosphere exchange. With the exception 
of one reoperation, no patient required future reoperation 
at an average follow-up of 3.6 ± 1.0 years (range, 1.5 to 5.2 
years). 
Within the stemmed group, 14 of 15 (93.3%) went 
on to 15 future surgeries (two spacer revisions, one resec-
tion arthroplasty, one long-stemmed hemiarthroplasty, 
four total shoulder arthroplasties, and seven reverse shoul-
der arthroplasties) with 12 of 15 (80.0%, p = 0.427) under-
going definitive reimplantation at an average of 2.4 ± 0.7 
months (range, 0.7 to 4.4 months) after the index spacer 
placement (Table 3). In those stemmed patients who were 
converted to a revision arthroplasty, 8 of 12 (66.7%) had 
final range of motion data at an average follow-up of 18.8 
± 8.5 months (range, 6.4 to 35.8 months). These patients 
had an average forward elevation of 94° ± 43° (range, 30° 
to 150°; p = 0.300). The operative time for definitive reim-
plantation after stemmed spacer placement was 154 ± 70.1 
minutes (range, 57 to 304 minutes; p = 0.653). There were 
three complications during reimplantation in the stemmed 
spacer group. One patient was found to have a dislocated 
reverse shoulder arthroplasty in the recovery room on 
postoperative radiographs at which point the patient was 
brought back to the operating room for closed reduc-
tion. Two patients were found to have atrophy and loss of 
contractility of the anterior and middle deltoid. One had 
a confirmed diagnosis of axillary nerve palsy on electro-
myography that self-resolved within 6 months, while the 
other refused electromyography and had an incomplete 
return of function. Intraoperative cultures were recorded 
for 11 of 12 reimplantations in the stemmed group with 3 
of 11 (27.3%) having at least one positive culture. In these 
Table 3. Surgical Variables for All Patients That Underwent Stemmed Spacer Placement
Sex Age (yr) Diagnosis at time of spacer placement Months to reimplantation
Surgery at 
reimplantation
Reoperation after 
reimplantation
Female 70.1 Infected HA for proximal humerus fracture from OSH NA NA NA
Male 48.0 Infected HA for RA from OSH 3.5 Long stem HA No
Male 57.6 Infected HA for CTA from OSH 1.9 RTSA No
Female 61.7 Loosening of HA for proximal humerus fracture from OSH 1.2 RTSA No
Female 62.9 Infected HA for proximal humerus fracture from OSH 3.5 RTSA No
Male 60.3 Infected TSA and rotator cuff tear from OSH 3.7 RTSA No
Female 60.0 Septic arthritis after arthroscopic debridement from OSH 1.2 RTSA No
Male 57.7 Primary septic arthritis from injection with I&D at OSH 0.9 RTSA No
Female 70.8 Chronic osteomyelitis after open acromioplasty at OSH 0.7 RTSA No
Female 64.1 Infected HA for proximal humerus fracture from OSH NA NA NA
Female 65.7 Glenoid and humeral loosening of TSA from OSH–Nickel allergy 3.6 Nickel free TSA No
Female 51.7 Glenoid and humeral loosening of TSA from OSH–Nickel allergy 2.3 Nickel free TSA No
Female 70.8 Painful HA with glenoid wear from OSH–elevated ESR/CRP 1.4 TSA No
Male 59.4 Osteomyelitis after rotator cuff repair from OSH 4.4 TSA No
Male 81.9 TSA with glenoid erosion from OSH NA NA NA
HA: hemiarthroplasty, OSH: outside hospital, NA: not applicable, RA: rheumatoid arthritis, CTA: cuff tear arthropathy, RTSA: reverse total shoulder arthroplasty, 
TSA: total shoulder arthroplasty, I&D: irrigation and debridement, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein.
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three patients, one grew E. coli (one colony in broth only; 
grew P. acnes at the index spacer placement) and two grew 
an unspecified bacillus species (both one colony in broth 
only; both were negative at the index spacer placement). 
These were all treated as contaminant without clinical 
evidence of infection postoperatively. Following reim-
plantation from a stemmed spacer, there were no further 
reoperations performed at an average follow-up of 4.0 ± 0.8 
years (range, 2.4 to 5.2 years). There were no clinical rein-
fections in either the stemless or stemmed population.
DISCUSSION
The role of two-stage revision in management of shoulder 
PJI has been well-described.3-9) Spacer placement is a vi-
able option either as a bridge to reimplantation or as a de-
finitive treatment modality. In our study, over three quar-
ters of patients went on to have revision arthroplasty while 
the rest retained the spacer as a definitive implant. In both 
groups, the infection was adequately treated as there were 
no clinical signs of recurrent infections. Additionally, there 
was only one reoperation after reimplantation (glenosphere 
exchange for a reverse shoulder arthroplasty at 6 weeks 
after reimplantation), and there was no statistical differ-
ence between the stemmed and stemless spacers in terms 
of eventual reimplantation.
In hip and knee PJI, recent analyses found improved 
functional outcomes and better soft tissue preservation of 
dynamic spacers when compared to static spacers.16-18) Pri-
or to this study, there has not been an analysis on the ideal 
antibiotic spacer design in shoulder PJI. One advantage of 
stemless spacers that we expected was reduced operative 
time since the implant can be made from the beginning 
of the case and is easily inserted in the joint. However, we 
found similar operative times for implantation of both de-
signs. It is likely that the operative time of complex shoul-
der PJI cases is driven by a number of technical variables, 
such as ease of stem excision, and that the effect of spacer 
type is negligible. Additionally, operative time of reim-
plantation was similar between the groups. This suggests 
that both implant types equally maintained the joint space 
and both are equally easy to remove upon revision surgery. 
Finally, the similar range of motion data after definitive 
reimplantation suggests that the choice of a stemmed or 
stemless implant does not have a major impact on the final 
functional outcome. While neither group returned to full 
range of motion, they did achieve similar forward eleva-
tion to that previously described for revision of hemiar-
throplasty to reverse total shoulder arthroplasty.22,23)
There were five total complications in the entire 
study group, two with index stemless spacer placement 
and three with reimplantation after stemmed implant 
placement. These complications included four neurologic 
injuries and one reverse shoulder arthroplasty dislocation. 
There were 70 total surgeries performed in our entire pop-
ulation which gives a neurologic injury rate of 5.7%, three 
of which completely resolved and one of which incom-
pletely resolved. The literature reports a rate of neurologic 
injury of 1% to 4.3% in anatomic total shoulder arthro-
plasty24,25) and from 1.7% to 11.6% in reverse shoulder ar-
throplasty26-28) with revision surgery being a risk factor for 
neurologic injury.29) The rate of neurologic injury in our 
patient population is within the range we expected given 
the complex nature of these cases. Three of these neuro-
logic deficits fully resolved while one partially resolved, 
consistent with previous reports of these injuries being 
stretch neuropraxias rather than transection injuries.25,27) 
Regarding bacterial cultures at the time of reimplantation, 
all patients that had one or less positive culture at the time 
of reimplantation were treated as a contaminant while 
those with two or more positive cultures were treated as 
true positive cultures per the protocol described by Fran-
giamore et al.30) The two patients that met this criteria of 
culture positivity at the time of reimplantation were given 
6 weeks of postoperative antibiotics. There were no rein-
fections after reimplantation in this study.
The findings of this study must be considered in the 
context of the limitations. First, the majority of our pa-
tients went on to have revision arthroplasty, which did not 
allow us to further study the differences between stemmed 
and stemless spacers as a final treatment option. Also, we 
did not have sufficient patient reported outcomes to fully 
analyze functional differences. While similar outcomes in 
forward elevation may provide a general idea of functional 
level, the availability of other outcomes, such as patient-
specific functional results, would have been more substan-
tial. Additionally, this is a purely retrospective study and 
therefore we can only determine associative relationships 
rather than speculate on causality. These were also very 
complex patients from both medical and technical per-
spectives. Therefore, retrospective analysis of the details 
of their clinical course is difficult. In order to mitigate this 
weakness, all of the patient charts were reviewed directly 
in their entirety instead of simply relying on the insti-
tutional database. Finally, because this was a retrospec-
tive study, the patient numbers were set without power 
analysis. Therefore, the nonsignificant trend of a higher 
reimplantation rate in patients with stemmed spacers may 
simply be a result of an underpowered study rather than 
truly nonsignificant.
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This study offers the first comparison between pa-
tients with stemmed antibiotic spacers and stemless anti-
biotic spacers in shoulder arthroplasty. The patient popu-
lations that underwent stemmed and stemless antibiotic 
spacer placement were statistically similar in complication 
rate, final reimplantation rate, operative time, and final 
active forward elevation. When analyzing all antibiotic 
spacers, over 70% were converted to revision arthroplas-
ties, after which there was one reoperation and no clinical 
reinfections. The results of this study do not suggest su-
periority of either stemmed or stemless antibiotic spacers. 
Future prospective analysis may determine differences in 
outcomes not observed in this study.
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